Novavax, Inc. (NVAX)
6.785
-0.12
(-1.81%)
USD |
NASDAQ |
Dec 08, 16:00
6.80
+0.02
(+0.22%)
After-Hours: 18:34
Novavax Shareholders Equity (Quarterly): -156.67M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | 92.80B |
| Moderna, Inc. | 9.33B |
| Merck & Co., Inc. | 51.85B |
| Sangamo Therapeutics, Inc. | 6.243M |
| Arcturus Therapeutics Holdings, Inc. | 224.56M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.180B |
| Total Liabilities (Quarterly) | 1.337B |
| Debt to Equity Ratio | -1.603 |
| Current Ratio | 2.267 |
| Net Debt Paydown Yield | -0.25% |